NCK2 and melanoma: In the present study, using human melanoma cell lines harboring the activating B-RAF (V600E) mutation, that are well defined for stage of cancer progression [19,20], we demonstrate that Nck2 protein and mRNA levels are increased in human metastatic melanoma cells compared with human primary melanoma cells that rarely metastasis.